Radian Group (NYSE:RDN – Get Free Report) had its price target hoisted by equities researchers at UBS Group from $33.00 to $34.00 in a report released on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the insurance provider’s stock. UBS Group’s price objective suggests a potential upside of 4.94% from the company’s previous close.
Separately, Keefe, Bruyette & Woods lowered their price target on shares of Radian Group from $41.00 to $40.00 and set an “outperform” rating for the company in a report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $36.80.
Radian Group Trading Down 1.1 %
Radian Group (NYSE:RDN – Get Free Report) last announced its earnings results on Wednesday, February 5th. The insurance provider reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $0.92 by $0.17. Radian Group had a return on equity of 13.96% and a net margin of 46.85%. Equities analysts forecast that Radian Group will post 3.79 EPS for the current fiscal year.
Insider Activity at Radian Group
In other Radian Group news, insider Derek Brummer sold 14,705 shares of Radian Group stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $34.65, for a total transaction of $509,528.25. Following the sale, the insider now directly owns 171,830 shares in the company, valued at $5,953,909.50. The trade was a 7.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.16% of the company’s stock.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in the stock. Blue Trust Inc. grew its stake in Radian Group by 352.4% in the third quarter. Blue Trust Inc. now owns 2,502 shares of the insurance provider’s stock worth $87,000 after purchasing an additional 1,949 shares in the last quarter. Assenagon Asset Management S.A. grew its position in shares of Radian Group by 272.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 828,058 shares of the insurance provider’s stock worth $28,725,000 after acquiring an additional 605,956 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Radian Group by 10.1% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 91,818 shares of the insurance provider’s stock valued at $3,197,000 after acquiring an additional 8,439 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its holdings in Radian Group by 4.2% in the third quarter. DekaBank Deutsche Girozentrale now owns 133,340 shares of the insurance provider’s stock worth $4,553,000 after purchasing an additional 5,392 shares during the period. Finally, First Trust Direct Indexing L.P. increased its stake in Radian Group by 9.9% during the third quarter. First Trust Direct Indexing L.P. now owns 7,200 shares of the insurance provider’s stock valued at $250,000 after purchasing an additional 650 shares during the last quarter. 95.33% of the stock is owned by institutional investors and hedge funds.
Radian Group Company Profile
Radian Group Inc, together with its subsidiaries, engages in the mortgage and real estate services business in the United States. It operates through two segments, Mortgage Insurance and Homegenius segments. The Mortgage Insurance segment aggregates, manages, and distributes U.S. mortgage credit risk for mortgage lending institutions and mortgage credit investors, through private mortgage insurance on residential first-lien mortgage loans; and other credit risk management solutions, including contract underwriting.
See Also
- Five stocks we like better than Radian Group
- ETF Screener: Uses and Step-by-Step Guide
- Intel Surges on M&A Talks: Rally Beginning or Just a Headfake?
- Investing in Commodities: What Are They? How to Invest in Them
- Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
- The Risks of Owning Bonds
- Up Nearly 1000%, Can AppLovin Keep Delivering for Investors?
Receive News & Ratings for Radian Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radian Group and related companies with MarketBeat.com's FREE daily email newsletter.